Genomics may be the key to identifying, curing and preventing diseases, changing the life sciences industry as we know it.
Join our industry experts as they analyze and align on a future vision for genomics.
This discussion will explore:
- The promises and challenges genomics presents.
- The unique innovation advantages and challenges larger NYSE companies face compared to smaller biotechs.
- How to democratize access to essential data across the R&D value chain.
- The critical importance of implementing and complying with appropriate consent policies and procedures.
- When this will all become a reality.
Click here to register.